ArticleJournal, genetic engineering & biotechnology2025
A simplified method for immunostaining single endometrial and liver organoids.
Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organoids derived from tissues such as the endometrium and liver represent crucial models for investigating cellular and molecular processes in a three-dimensional framework. These systems enable detailed studies of organ development and disease pathology through various methods, including immunostaining, for precise visualization and localization of specific proteins. This simplified method outlines a systematic protocol for isolating, culturing, and immunostaining individual organoids using transwell inserts. This streamlined method optimizes procedures for fixation, permeabilization, and single or double antibody staining, ensuring robust and reproducible outcomes. Our method allows selecting a single organoid in a temporal manner without disturbing the 3D structure of Matrigel domes. By standardizing these critical steps, researchers can efficiently utilize organoid cultures to advance our understanding of complex biological mechanisms and explore therapeutic interventions targeting diseases affecting the endometrium and liver.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.